UK markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
273.25+3.31 (+1.23%)
As of 3:02PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close269.94
Open269.88
Bid272.24 x 800
Ask272.47 x 1000
Day's range267.02 - 273.55
52-week range223.25 - 468.55
Volume1,025,825
Avg. volume983,798
Market cap40.139B
Beta (5Y monthly)0.47
PE ratio (TTM)21.85
EPS (TTM)12.50
Earnings date20 Oct 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est364.93
  • Motley Fool

    3 Big Problems With Biogen's Q3 Results

    Biogen (NASDAQ: BIIB) announced its third-quarter results on Wednesday. It's certainly true that Biogen did top analysts' estimates on both the top and bottom lines. Instead, there were three big problems with Biogen's Q3 results.

  • Motley Fool

    Why Ionis Pharmaceuticals Stock Is Down 13% This Week

    Shares of Ionis Pharmaceuticals (NASDAQ: IONS), a biotechnology company, have fallen around 13.6% since their closing price on Friday, Oct. 15, 2021. Investors were disappointed by phase 3 clinical trial results for tofersen, an experimental treatment for amyotrophic lateral sclerosis. Treatment with tofersen was supposed to help reduce physical symptoms of ALS, a progressive neurodegenerative disorder that affects around 20,000 new U.S. patients annually.